$NVAX Kate Bingham; from FT interview this weekend - ft.com/content/8d9edc58-792... - ; “While AstraZeneca’s low cost and ease of storage make it a frontrunner to be the leading “vaccine for the world”, a jab made by Novavax, a US biotech company, “is going to be hot on its heels”, Bingham says. Indeed, she has a rather special answer to a favourite question among middle-aged Britons: “AstraZeneca or Pfizer?” She can reply: “Neither. I’m Novavax.”
2
9
9 Likes